Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07358520
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years;
* Histopathologically confirmed diagnosis of lung cancer;
* Receiving Bevacizumab or Anlotinib treatment;
* Positive urine protein detection, with 0.15g \< 24-hour urinary protein quantification \< 3.5g;
* No treatment with Huaier Granules within one month prior to enrollment;
* Expected survival time not less than 6 months;
* Voluntary participation in this study and provision of signed informed consent.
Exclusion Criteria:
* Known allergy, contraindication, or caution to any component of Huaier Granules;
* Inability to take oral medication;
* Required or ongoing use of drugs known to potentially affect proteinuria, including but not limited to ACE inhibitors, glucocorticoids (\>3 weeks), and Chinese patent medicines (as per respective drug prescribing information);
* Proteinuria caused by underlying diseases, including but not limited to nephropathy, hypertension, urinary tract infection, systemic lupus erythematosus, multiple myeloma, etc.;
* Women who are pregnant, breastfeeding, or planning pregnancy;
* Currently participating in other clinical trials investigating drugs for treating proteinuria;
* Refusal to cooperate with follow-up;
* Any other reasons deemed by the investigator as unsuitable for participation in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07358520
Study Brief:
Protocol Section:
NCT07358520